Hernández Prat, A. (2017). Antitumor effects of novel targeted therapies (TAK-228 and TAK-117) with high selectivity againts PI3K/AKT/mTOR pathway in bladder cancer: Defining molecular markers.
Citación estilo ChicagoHernández Prat, Anna. Antitumor Effects of Novel Targeted Therapies (TAK-228 and TAK-117) With High Selectivity Againts PI3K/AKT/mTOR Pathway in Bladder Cancer: Defining Molecular Markers. 2017.
Cita MLAHernández Prat, Anna. Antitumor Effects of Novel Targeted Therapies (TAK-228 and TAK-117) With High Selectivity Againts PI3K/AKT/mTOR Pathway in Bladder Cancer: Defining Molecular Markers. 2017.
Precaución: Estas citas no son 100% exactas.